MAINA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 19.628
EU - Europa 17.579
AS - Asia 6.340
SA - Sud America 668
OC - Oceania 318
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 61
Totale 44.749
Nazione #
US - Stati Uniti d'America 18.968
IT - Italia 6.001
CN - Cina 3.492
IE - Irlanda 2.062
FR - Francia 1.581
DE - Germania 1.345
SE - Svezia 1.148
UA - Ucraina 1.096
KR - Corea 965
FI - Finlandia 926
GB - Regno Unito 899
PL - Polonia 604
CA - Canada 497
VN - Vietnam 405
ES - Italia 378
BR - Brasile 328
JP - Giappone 312
IN - India 280
AU - Australia 268
NL - Olanda 260
BE - Belgio 243
RU - Federazione Russa 215
TR - Turchia 211
TW - Taiwan 157
CH - Svizzera 131
MX - Messico 128
CL - Cile 100
GR - Grecia 100
RO - Romania 100
PT - Portogallo 98
AT - Austria 95
DK - Danimarca 95
SG - Singapore 90
HK - Hong Kong 88
CO - Colombia 78
AR - Argentina 67
ID - Indonesia 62
EU - Europa 58
NZ - Nuova Zelanda 50
IR - Iran 47
EC - Ecuador 44
TH - Thailandia 43
IL - Israele 41
PE - Perù 41
NO - Norvegia 40
ZA - Sudafrica 39
EG - Egitto 35
PK - Pakistan 25
RS - Serbia 22
HU - Ungheria 20
NG - Nigeria 20
CZ - Repubblica Ceca 18
HR - Croazia 18
MY - Malesia 18
LT - Lituania 17
TN - Tunisia 17
LK - Sri Lanka 15
SI - Slovenia 15
IS - Islanda 14
PH - Filippine 14
CR - Costa Rica 13
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 10
MA - Marocco 9
BG - Bulgaria 8
IQ - Iraq 8
LB - Libano 8
BA - Bosnia-Erzegovina 7
BD - Bangladesh 6
GT - Guatemala 6
KE - Kenya 6
NP - Nepal 6
AL - Albania 5
MO - Macao, regione amministrativa speciale della Cina 5
MU - Mauritius 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
PR - Porto Rico 4
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
QA - Qatar 3
SN - Senegal 3
UZ - Uzbekistan 3
VE - Venezuela 3
A1 - Anonimo 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CU - Cuba 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RE - Reunion 2
SC - Seychelles 2
Totale 44.723
Città #
Beijing 2.458
Houston 2.234
Chandler 2.187
Dublin 2.042
Villeurbanne 896
Jacksonville 885
Fairfield 860
Ashburn 803
Medford 649
Ann Arbor 603
Princeton 603
Wilmington 545
Redwood City 542
Woodbridge 528
Torino 522
Warsaw 493
Milan 410
Seattle 407
Nyköping 385
Cambridge 312
Dearborn 306
Pisa 254
Boston 240
Rome 234
Turin 201
Dong Ket 199
Brussels 162
Boardman 134
Toronto 128
Verona 109
Shanghai 100
Nanjing 97
Norwalk 96
Taipei 95
Ottawa 89
Tokyo 85
Des Moines 82
Guangzhou 67
Hefei 67
London 67
New York 64
Piemonte 61
Fremont 60
Santiago 58
Hangzhou 57
Vienna 57
San Diego 56
Bologna 54
Falls Church 53
São Paulo 51
Padova 50
Florence 48
Amsterdam 46
Chengdu 45
Philadelphia 45
Madrid 44
Istanbul 42
Sydney 42
Lachine 41
Kunming 40
Palermo 40
Central District 38
Paris 38
Jinan 36
Pune 36
Seoul 36
Wuhan 34
Zhengzhou 34
Sudbury 32
Barcelona 31
Gainesville 31
Nanchang 31
Bari 30
Changsha 30
Chicago 30
Helsinki 29
Jakarta 29
Melbourne 29
Bangkok 28
Catania 28
Dallas 27
Mountain View 27
Raritan 27
Washington 27
Naples 26
Phoenix 26
Aarhus 25
Athens 25
Berlin 25
Buenos Aires 25
Hamburg 25
Medellín 25
Perugia 25
San Mateo 25
Central 24
Genova 24
Lima 24
New Taipei 24
Trieste 24
Brescia 23
Totale 23.343
Nome #
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 2.485
Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura 1.412
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 836
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. 728
Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder 567
Paliperidone palmitate and metabolic syndrome in patients with schizophrenia a 12-month observational prospective cohort study 543
Involuntary admissions in Italy: the impact of seasonality 438
Lithium-associated hyperparathyroidism and hypercalcaemia: A case-control cross-sectional study 418
Gender-related distribution of personality disorders in a sample of patients with panic disorder. 413
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. 393
Affective recurrences in bipolar disorder after switching from lithium to valproate or vice versa: A series of 57 cases 366
Increased uric acid levels in bipolar disorder subjects during different phases of illness. 365
Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions 338
Glucose metabolism alterations in patients with bipolar disorder. 337
Combining drug and psychological treatments for obsessive-compulsive disorder: What is the evidence, when and for whom 335
A randomized, single-blind comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression 332
Il temperamento ciclotimico nei pazienti con DOC. 323
Disturbi bipolari e d’ansia: aspetti epidemiologici e clinici. 301
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 300
High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder 293
Duloxetina e bupropione in pazienti con disturbo depressivo maggiore resistente agli SSRI 291
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 277
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. 274
Metabolic syndrome and Obsessive-Compulsive Disorder: a naturalistic Italian study 273
Sindrome metabolica e disturbi psichiatrici: confronto tra disturbo bipolare e disturbo ossessivo-compulsivo 268
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 268
Anticorpi anti-SNC in adulti con disturbo ossessivo-compulsivo 263
Anti-brain antibodies in adult patients with obsessive-compulsive disorder 255
Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase 253
Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. 253
General Medical Conditions Are Associated With Delay to Treatment in Patients with Bipolar Disorder. 246
Brief dynamic therapy and depression severity: a single-blind, randomized study. 238
Mania mista e antidepressivi: uno studio clinico su un campione di pazienti ricoverati per disturbo bipolare 237
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study 226
The role of the potassium channel gene KCNK2 in major depressive disorder 222
Obsessive-compulsive disorder and cyclothymic temperament: an exploration of clinical features 216
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study 216
Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates 211
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression 209
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 204
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: Long-term results 203
Cyclothymic temperament and major depressive disorder: A study on Italian patients 198
The use of antidepressants in bipolar disorder 187
Il disturbo ossessivo-compulsivo di personalità (DOCP): prevalenza nei pazienti con disturbi d'ansia e nei soggetti sani 178
Terapia farmacologica della distimia: uno studio di confronto fra amisulpride, fluoxetina e lorazepam 177
Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. 176
Efficacia e tollerabilità della Lofepramina nel trattamento della depressione nel paziente ambulatoriale 162
Diagnostic delay in ADHD: Duration of untreated illness and its socio-demographic and clinical predictors in a sample of adult outpatients 161
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. 153
Bipolar disorders: is there an influence of seasonality or photoperiod? 152
Differenze di genere nel disturbo ossessivo-compulsivo: uno studio clinico su 415 pazienti. 147
Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. 145
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 144
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy. 143
Disturbo ossessivo-compulsivo sottosoglia 142
Disturbo ossessivo-compulsivo con concomitanti disturbi da uso di sostanze: uno studio clinico 139
L’inquadramento nosografico dei disturbi dell’umore: dai sintomi alla diagnosi, dalla diagnosi alla terapia. 139
Paziente ricoverato per episodio maniacale : trattamento con asenapina in acuto e nel lungo termine 139
Can quetiapine extended release (ER) induce labial edema in a female patient with treatment-resistant major depressive episode? 139
Combined treatments in obsessive-compulsive disorder: current knowledge and future prospects. 138
Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. 137
L’intervento psicoeducazionale multifamiliare (IPM) nel disturbo ossessivo-compulsivo: uno studio pilota 137
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 133
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. 128
Il disturbo ossessivo-compulsivo. Epidemiologia e clinica. 128
Tecniche di stimolazione cerebrale nel trattamento della depressione resistente [Brain stimulation therapies for treatment-resistant depression]. 128
Gender related differences in the onset of panic disorder 127
Early childhood infections, antistreptococcal and basal ganglia antibodies in adult ADHD: a preliminary study 127
Correlates of violent suicide attempts in patients with bipolar disorder 124
The Impact of General Medical Conditions in Obsessive-Compulsive Disorder 124
Episodic and chronic obsessive-compulsive disorder. 122
L’intervento psicoeducazionale multifamiliare nel disturbo ossessivo-compulsivo 119
Common and specific blood microRNA alterations in unipolar and bipolar depression 119
La stimolazione del nervo vago (VNS) nel trattamento della depressione maggiore resistente: risultati preliminari di uno studio clinico sperimentale spontaneo 118
Impact of comorbid obsessive-compulsive disorder on suicidality in patients with bipolar disorder 118
Effectiveness of cognitive-behavioural therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study. 113
Hoarding e disturbo ossessivo-compulsivo (DOC): due entità cliniche distinte in comorbilità o hoarding secondario al DOC? 110
Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences 109
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder 109
Psychiatric and physical rehabilitation intensive approach for suicide attempters by jumping from heights 108
A 10-year evaluation on adolescents with anxiety disorders: are they at risk of bipolarity? 107
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 107
Fenomenologia del paziente con disturbo ossessivo-compulsivo ad esordio precoce e ad esordio in età adulta 104
Studio clinico sperimentale spontaneo sul trattamento della depressione maggiore resistente mediante stimolezione del nervo vago: risultati a due anni di follow-up 102
Trattamento farmacologico con sali di litio in pazienti affetti da disturbo bipolare: cosa succede al metabolismo del calcio? 102
[Generalized anxiety disorder. Clinical and nosological remarks] 101
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia. 100
Validità ed affidabilità del Quality of Life, Enjoyment and Satisfaction Questionnaire, versione breve 100
L’influenza della comorbidità con disturbo bipolare sulla clinica del disturbo ossessivo-compulsivo 99
Definizione e strategie terapeutiche della depressione resistente al trattamento: una revisione della letteratura 99
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 99
Ansia e disturbo bipolare: comorbilità o epifenomeno? 98
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context 96
Brief dynamic therapy combined with pharmacotherapy in the treatment of panic disorder with concurrent depressive symptoms. 95
[The general practitioner and psychiatric assistance. A study carried out in the Piedmont region] 93
La comorbidità del disturbo ossessivo-compulsivo con i disturbi di asse I: differenza tra i sessi e correlazione con il decorso clinico 93
Il trattamento del disturbo ossessivo-compulsivo resistente 93
Serum BDNF in OCD and major depressive disorder patients before and during antidepressant treatment. European neuropsychopharmacology 2010, 20 (3): S541-S541. 91
L'ipotesi autoimmune nel disturbo ossessivo-compulsivo: studio immunologico su un campione di pazienti adulti 91
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness 91
Totale 23.984
Categoria #
all - tutte 104.283
article - articoli 0
book - libri 0
conference - conferenze 27.455
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.935 0 0 0 0 0 0 0 0 207 415 980 333
2019/20207.419 330 363 529 738 529 1.647 756 512 758 420 460 377
2020/20216.052 583 299 560 345 502 432 746 299 673 489 456 668
2021/20225.262 307 252 326 303 326 255 364 378 348 276 712 1.415
2022/20238.533 891 545 335 730 702 2.143 817 566 756 252 508 288
2023/20243.438 529 675 282 361 374 488 273 397 59 0 0 0
Totale 46.506